Markets:

Overview

News

Currencies

International

Treasuries

Danaher Corp (NY:DHR)

180.63 +7.50 (+4.33%)

Official Closing Price Updated: 7:00 PM EDT, May 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)

May 21, 2026

Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Danaher (NYSE:DHR) and its p...

Via StockStory

Topics Economy

3 Profitable Stocks We’re Skeptical Of

April 27, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline? ↗

April 24, 2026

This blue chip stock has been in a multiyear slump, but things are looking up.

Via The Motley Fool

Topics Artificial Intelligence

Top gainers and losers in the S&P500 index during Thursday's after-hours session. ↗

April 23, 2026

Via Chartmill

Thursday's after hours session: top gainers and losers ↗

April 23, 2026

Via Chartmill

Discover which S&P500 stocks are making waves on Wednesday. ↗

April 22, 2026

Via Chartmill

DHR Q1 Deep Dive: Bioprocessing Momentum and Acquisition Strategy Drive Mixed Start to 2026

April 22, 2026

Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.7% year on year to...

Via StockStory

Danaher (DHR) Q1 2026 Earnings Call Transcript ↗

April 21, 2026

Danaher (DHR) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Danaher Corp. May Be the Smartest Bet in Biotech Right Now ↗

April 21, 2026

If biotech funding continues to increase this year, Danaher could benefit.

Via The Motley Fool

Topics Supply Chain

Danaher (NYSE:DHR) Misses Q1 CY2026 Revenue Estimates

April 21, 2026

Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.7% year on year to...

Via StockStory

Danaher (DHR) Q1 Earnings: What To Expect

April 19, 2026

Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market open. Here’s what to expect. Danaher met a...

Via StockStory

Topics Artificial Intelligence

AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages

April 09, 2026

Via Investor Brand Network

Topics Artificial Intelligence

AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages

April 09, 2026

From AINewsWire

Via GlobeNewswire

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

April 08, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron...

Via StockStory

Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse

April 07, 2026

Today marks a definitive turning point for Hologic, Inc. (NASDAQ: HOLX). As the company prepares to finalize its $18.3 billion acquisition by private equity giants Blackstone and TPG, it stands as a...

Via Finterra

Topics Artificial Intelligence Retirement World Trade

3 Reasons to Avoid DHR and 1 Stock to Buy Instead

April 02, 2026

Although the S&P 500 is down 2.8% over the past six months, Danaher’s stock price has fallen further to $190.75, losing shareholders 9.3% of their capital. T...

Via StockStory

Topics Stocks

The Often-Missed Corner of Healthcare That Wall Street Is Loving ↗

March 29, 2026

Via MarketBeat

Spotting Winners: Danaher (NYSE:DHR) And Research Tools & Consumables Stocks In Q4

March 23, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Danaher (NYSE:DHR) and its peers. Th...

Via StockStory

Topics Economy

1 S&P 500 Stock Worth Your Attention and 2 Facing Headwinds

March 13, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...

Via StockStory

Topics Stocks

The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal

March 10, 2026

As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise....

Via MarketMinute

Topics Artificial Intelligence Economy Government

Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks

March 09, 2026

As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

1 Profitable Stock to Target This Week and 2 We Avoid

March 02, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Masimo Corporation (Nasdaq – MASI), IHS Holding Limited (NYSE – HIS), VerifyMe, Inc. (Nasdaq – VRME), Great Lakes Dredge & Dock Corporation (Nasdaq – GLDD)

February 27, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026

February 27, 2026

WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the...

Via MarketMinute

Topics Earnings Economy World Trade

The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗

February 21, 2026

As AI uncertainty weighs on stocks, consider loading up on these dividend-growth blue chips instead.

Via The Motley Fool

Topics Artificial Intelligence

Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape

February 19, 2026

On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire...

Via MarketMinute

Danaher’s $9.9 Billion Acquisition of Masimo: A Strategic Pivot to the Future of Patient Monitoring

February 19, 2026

In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire...

Via MarketMinute

Topics Artificial Intelligence Economy

Naya Capital Adds Masimo Shares ↗

February 19, 2026

Masimo supplies noninvasive monitoring tech to hospitals and care providers, serving both medical and consumer health markets worldwide.

Via The Motley Fool

Topics Regulatory Compliance

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky

February 18, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Billionaire Investors Warren Buffett, Bill Ackman and Other Have Been Buying These Stocks ↗

February 18, 2026

Every quarter, we get to see what the best of the best have bought and sold.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.